As Sanofi anticipates sales of immunotherapy juggernaut Dupixent reaching a major $22 billion by the end of the decade, ...

FUJIFILM has invested about $4 billion in building biopharmaceutical manufacturing sites and life sciences capabilities.

This was the stock's third consecutive day of gains.

Roche (RHHBY) expects an increase in Group sales in the mid single digit range at CER. Core earnings per share are targeted to develop in the ...

Group sales grew by 6% at constant exchange rates; 7% in CHF, driven by high demand for newer medicines and diagnostic solutions. Roche (RHHBY) ...

Wall Street analysts expect Regeneron (REGN) to post quarterly earnings of $8.76 per share in its upcoming report, which indicates a year-over-year decline of 8.3%. Revenues are expected to be $3.25 ...

Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of ...